Mary Beth Johnston is the co-leader of the global health care and FDA practice group and has served on the firm’s management committee since 2008. She concentrates her practice exclusively in health law, representing major academic medical centers, hospital and health systems, accountable care organizations and provider networks, and pharmacy and clinical laboratory providers.
As a result of this diversified practice, her proficiency extends to federal and state regulatory compliance matters, Medicare and Medicaid reimbursement, FCA and internal investigations, faculty practice plan and other physician compensation models, provider network development and managed care, and health care corporate governance matters. She likewise maintains an active transactional practice, representing clients on hospital acquisitions and joint ventures, as well as health system development and reorganizations. She is an active author and speaker on critical issues affecting the health care industry.
